Trending News
News
News
Preclinical Study Suggests Steps Toward Non-Addictive Painkillers
A preclinical study led by Indiana University scientists reports a promising step forward in the search for pain relief methods without the addictive side effects behind the country's current opioid addiction crisis.
News
Why is Egg-based Production of the Flu Vaccine Causing Issues?
According to a new study from scientists at The Scripps Research Institute (TSRI), the common practice of growing influenza vaccine components in chicken eggs disrupts the major antibody target site on the virus surface, rendering the flu vaccine less effective in humans.
News
Lead Poisoning Risk in Imported Sweets
The California Department of Public Health issued more alerts for lead in candy than for the other top three sources of food-borne contamination combined a study found.
News
Examining Potatoes' Past Could Improve Spuds of the Future
Scientists have analyzed cultivated potatoes and their wild relatives using modern genomics approaches to reveal key factors that could address food security in 21st century agriculture.
News
Variability in How Cancer Cells Respond to Drugs Investigated
A study led by scientists from Harvard Medical School reveals “hidden” variability in how tumor cells are affected by anticancer drugs, offering new insights on why patients with the same form of cancer can have different responses to a drug.
News
3D Molecular Map Helps Researchers Pinpoint Novel Cancer Treatments
Researchers have produced the first three-dimensional (3D) map of a molecular 'scaffold' called SgK223, known to play a critical role in the development and spread of aggressive breast, colon and pancreatic cancers.
News
Bioenergetic Changes Seen in Stem Cells from Late Onset Alzheimer's Disease Patients
Researchers find bioenergetic abnormalities may be an inherent mechanism underlying Late Onset Alzheimer's Disease
News
New ‘Double Decker’ Antibody-drug Conjugates Fight Cancer
Scientists have created a new class of antibody-drug conjugates (ADCs), using a versatile “double decker” technology that ties antibodies and a drug together to produce highly potent pharmaceuticals for cancer therapy.
News
Concept Life Sciences Announces Acquisition of Aquila BioMedical
Acquisition adds immuno-oncology capability to broaden Concept’s range of integrated drug discovery and development services.
News
Mologic Strengthens Team with the Appointment of General Manager
Commercial team expands to build on R&D successes and drive Company growth.
Advertisement